Differences Are Important: Breast Cancer Therapy in Different Ethnic Groups

por Costa, Ricardo L.B., Gradishar, William J.
Publicado 2017

Clinical development of immunotherapies for HER2(+) breast cancer: a review of HER2-directed monoclonal antibodies and beyond

por Costa, Ricardo L. B., Czerniecki, Brian J.
Publicado 2020

Occult Breast Carcinoma Presenting as Scalp Metastasis

por Costa, Ricardo L.B., Costa-Filho, Rubens B., Rosa, Marilin, Czerniecki, Brian J.
Publicado 2017

A systematic review and meta-analysis of selected toxicity endpoints of alpelisib

por Shields, Misty, Mo, Qianxing, Armitage, Melissa, Sharpe, Susan C., Costa, Ricardo L.B.
Publicado 2020

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy

por Talamantes, Sarah, Xie, Eric, Costa, Ricardo L. B., Chen, Melissa, Rademaker, Alfred, Santa‐Maria, Cesar A.
Publicado 2020

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy

por Artzy-Randrup, Yael, Epstein, Tamir, Brown, Joel S., Costa, Ricardo L. B., Czerniecki, Brian J., Gatenby, Robert A.
Publicado 2021

A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes

por Bari, Shahla, Boulware, David, Li, Jiannong, Loftus, Loretta, Soyano Muller, Aixa, Jameel, Zena, Khong, Hung, Czerniecki, Brian J, Costa, Ricardo L B
Publicado 2022

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma

por Costa, Rubens Barros, Benson, Al, Yaghmai, Vahid, Costa, Ricardo L. B., Zhou, Haijun, Behdad, Amir, Kaplan, Jason B., Sadim, Maureen, Talamantes, Sarah, Kalyan, Aparna
Publicado 2018

A mixed‐methods study of cyclin‐dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers

por Oswald, Laura B., Arredondo, Brandy, Kadono, Mika, Martinez‐Tyson, Dinorah, Meade, Cathy D., Penedo, Frank, Antoni, Michael H., Soliman, Hatem, Costa, Ricardo L. B., Jim, Heather S. L.
Publicado 2021

Long-Term CD4(+) T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study

por Gallen, Corey, Dukes, Christopher W., Aldrich, Amy, Macaisa, Lauren, Mo, Qianxing, Cubitt, Christopher L., Pilon-Thomas, Shari, Giuliano, Anna R., Czerniecki, Brian J., Costa, Ricardo L. B.
Publicado 2022

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer

por Costa, Rubens Barros, Costa, Ricardo L.B., Talamantes, Sarah M., Kaplan, Jason B., Bhave, Manali A., Rademaker, Alfred, Miller, Corinne, Carneiro, Benedito A., Mahalingam, Devalingam, Chae, Young Kwang
Publicado 2018

Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma

por Ramamoorthi, Ganesan, Kodumudi, Krithika, Snyder, Colin, Grover, Payal, Zhang, Hongtao, Greene, Mark I, Basu, Amrita, Gallen, Corey, Wiener, Doris, Costa, Ricardo L B, Han, Hyo S, Koski, Gary, Czerniecki, Brian J
Publicado 2022

Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study

por Barakat, Elie, Bibok, Andras, Rishi, Anupam, Ahmed, Altan, Frakes, Jessica M., Hoffe, Sarah E., Armaghani, Avan J., Soyano, Aixa E., Costa, Ricardo L.B., El-Haddad, Ghassan, Choi, Junsung, Kis, Bela
Publicado 2021

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the...

por Kodumudi, Krithika N., Ramamoorthi, Ganesan, Snyder, Colin, Basu, Amrita, Jia, Yongsheng, Awshah, Sabrina, Beyer, Amber P., Wiener, Doris, Lam, Lian, Zhang, Hongtao, Greene, Mark I., Costa, Ricardo L. B., Czerniecki, Brian J.
Publicado 2019

Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia

por Sun, James, Zhong, Xiaojun, Ma, Junjie, Sun, Weihong, Han, Hyo S., Soliman, Hatem H., Loftus, Loretta S., Costa, Ricardo L. B., Armaghani, Avan J., Soyano‐Muller, Aixa E., Czerniecki, Brian J., Lee, M. Catherine, Kiluk, John V., Khakpour, Nazanin, Hoover, Susan J., Laronga, Christine, Khong, Hung T.
Publicado 2021

Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway

por Jia, Yongsheng, Kodumudi, Krithika N., Ramamoorthi, Ganesan, Basu, Amrita, Snyder, Colin, Wiener, Doris, Pilon-Thomas, Shari, Grover, Payal, Zhang, Hongtao, Greene, Mark I., Mo, Qianxing, Tong, Zhongsheng, Chen, Yong-Zi, Costa, Ricardo L.B., Han, Hyo, Lee, Catherine, Soliman, Hatem, Conejo-Garcia, Jose R., Koski, Gary, Czerniecki, Brian J.
Publicado 2021

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study

por Ahmed, Kamran A., Kim, Youngchul, Arrington, John A., Kim, Sungjune, DeJesus, Michelle, Soyano, Aixa E., Armaghani, Avan J., Costa, Ricardo L.B., Khong, Hung T., Loftus, Loretta S., Rosa, Marilin, Caudell, Jimmy J., Diaz, Roberto, Robinson, Timothy J., Etame, Arnold B., Tran, Nam D., Sahebjam, Solmaz, Soliman, Hatem H., Czerniecki, Brian J., Forsyth, Peter A., Yu, H. Michael, Han, Hyo S.
Publicado 2021